112 related articles for article (PubMed ID: 37695827)
1. Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane-Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl).
Díaz-Sánchez L; Zentella-Dehesa A; Castro-Torres VA; Silva-Jiménez N; Jacobo-Herrera NJ; Martínez-Vázquez M
Chem Biodivers; 2023 Oct; 20(10):e202300893. PubMed ID: 37695827
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of a triterpene-enriched fraction of Cecropia pachystachya on the human hormone-refractory prostate cancer PC3 cell line.
Rosa HH; Carvalho P; Ortmann CF; Schneider NFZ; Reginatto FH; Simões CMO; Silva IT
Biomed Pharmacother; 2020 Oct; 130():110551. PubMed ID: 32768881
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes.
Chávez IO; Apan TR; Martínez-Vázquez M
J Pharm Pharmacol; 2005 Sep; 57(9):1087-91. PubMed ID: 16105229
[TBL] [Abstract][Full Text] [Related]
4. The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.
Lopez Lopez R; van Rijswijk RE; Wagstaff J; Pinedo HM; Peters GJ
Eur J Cancer; 1994; 30A(10):1545-9. PubMed ID: 7833116
[TBL] [Abstract][Full Text] [Related]
5. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells.
Wróblewska-Łuczka P; Grabarska A; Florek-Łuszczki M; Plewa Z; Łuszczki JJ
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430369
[TBL] [Abstract][Full Text] [Related]
6.
Sotelo-Barrera M; Cília-García M; Luna-Cavazos M; Díaz-Núñez JL; Romero-Manzanares A; Soto-Hernández RM; Castillo-Juárez I
Plants (Basel); 2022 Jul; 11(13):. PubMed ID: 35807718
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori activity of anacardic acids from Amphipterygium adstringens.
Castillo-Juárez I; Rivero-Cruz F; Celis H; Romero I
J Ethnopharmacol; 2007 Oct; 114(1):72-7. PubMed ID: 17768020
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines.
Voigt W; Bulankin A; Müller T; Schoeber C; Grothey A; Hoang-Vu C; Schmoll HJ
Clin Cancer Res; 2000 May; 6(5):2087-93. PubMed ID: 10815936
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
[TBL] [Abstract][Full Text] [Related]
12. Synergistic enhancement by interleukin-1 alpha of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice.
Johnson CS; Chang MJ; Yu WD; Modzelewski RA; Grandis JR; Vlock DR; Furmanski P
Cancer Chemother Pharmacol; 1993; 32(5):339-46. PubMed ID: 8339383
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
[TBL] [Abstract][Full Text] [Related]
14. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
15. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times.
Xu YY; Jiang N; Liu TS; Qu HQ; Wang T
Mol Med Rep; 2012 Nov; 6(5):1075-80. PubMed ID: 22895541
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell lines.
Sark MW; Timmer-Bosscha H; Meijer C; Uges DR; Sluiter WJ; Peters WH; Mulder NH; de Vries EG
Br J Cancer; 1995 Apr; 71(4):684-90. PubMed ID: 7710929
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin.
Sabatino MA; Colombo T; Geroni C; Marchini S; Broggini M
Clin Cancer Res; 2003 Nov; 9(14):5402-8. PubMed ID: 14614026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
